Global Cell and Gene Therapy Supply Chain Solution Market Growth (Status and Outlook) 2024-2030

Global Cell and Gene Therapy Supply Chain Solution Market Growth (Status and Outlook) 2024-2030

The global Cell and Gene Therapy Supply Chain Solution market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Cell and Gene Therapy Supply Chain Solution Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Supply Chain Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Supply Chain Solution sales for 2023 through 2029. With Cell and Gene Therapy Supply Chain Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Supply Chain Solution industry.

This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Supply Chain Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy Supply Chain Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Supply Chain Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Supply Chain Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Supply Chain Solution.

United States market for Cell and Gene Therapy Supply Chain Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Cell and Gene Therapy Supply Chain Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Cell and Gene Therapy Supply Chain Solution is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Cell and Gene Therapy Supply Chain Solution players cover Cencora, Inc（World Courier）, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Supply Chain Solution market by product type, application, key players and key regions and countries.

Segmentation by Type:
Courier Company Provided
Hosted Logistics Company Provided

Segmentation by Application:
Biotech and Pharmaceutical Companies
Hospitals
Research Organizations
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Courier Company Provided
Hosted Logistics Company Provided

Segmentation by Application:
Biotech and Pharmaceutical Companies
Hospitals
Research Organizations
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cencora, Inc（World Courier）
QuickStat
Associated Couriers, LLC
Central Pharma
POLAR EXPRES
Biocair
time:matters
Mercury Business Services
Cardinal Health
CRYOPDP
Cryoport
NMDP BioTherapies
McKesson
Excel Courier
Almac
BEAM Logistics

Please note: The report will take approximately 2 business days to prepare and deliver.